These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23172418)

  • 1. Inadvertent ophthalmic administration of atropine drops in a hospice patient.
    Bascom PB
    Am J Hosp Palliat Care; 2013 Dec; 30(8):793-4. PubMed ID: 23172418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of atropine 1% ophthalmic solution administered sublingually for the management of terminal respiratory secretions.
    Protus BM; Grauer PA; Kimbrel JM
    Am J Hosp Palliat Care; 2013 Jun; 30(4):388-92. PubMed ID: 22833553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic adverse effects of topical ocular instillation of atropine in two children].
    Princelle A; Hue V; Pruvost I; Potey C; Dubos F; Martinot A
    Arch Pediatr; 2013 Apr; 20(4):391-4. PubMed ID: 23433845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atropine eyedrops for death rattle in a terminal cancer patient.
    Shinjo T; Okada M
    J Palliat Med; 2013 Feb; 16(2):212-3. PubMed ID: 22747099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription of eye drops.
    O'Sullivan EP; Malhotra R; Migdal C
    Postgrad Med J; 2001 Oct; 77(912):654-5. PubMed ID: 11571373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual atropine drops for the treatment of pediatric sialorrhea.
    Rapoport A
    J Pain Symptom Manage; 2010 Nov; 40(5):783-8. PubMed ID: 20541902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic Atropine: A Typical Anticholinergic Toxidrome From an Atypical Old Culprit.
    Raschka M; Khant M
    J Pediatr Pharmacol Ther; 2023; 28(6):565-567. PubMed ID: 38130339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atropine-induced toxicity after off-label sublingual administration of eyedrop for sialorrhoea treatment in neurological disabled patients.
    Michelon H; Larabi IA; Lemoine J; Alvarez JC; Genevée A; Lillo-Lelouet A; Azouvi P; Lefèvre-Dognin C; Paquereau J
    Br J Clin Pharmacol; 2021 Aug; 87(8):3364-3369. PubMed ID: 33521988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atropine for the treatment of childhood myopia.
    Chua WH; Balakrishnan V; Chan YH; Tong L; Ling Y; Quah BL; Tan D
    Ophthalmology; 2006 Dec; 113(12):2285-91. PubMed ID: 16996612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifocal electroretinogram in children on atropine treatment for myopia.
    Luu CD; Lau AM; Koh AH; Tan D
    Br J Ophthalmol; 2005 Feb; 89(2):151-3. PubMed ID: 15665343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Hospice Disenrollment and Hospitalization With Continuous Home Care Provision.
    Wang SY; Dang W; Aldridge MD; Canavan M; Cherlin E; Bradley E
    Med Care; 2017 Sep; 55(9):848-855. PubMed ID: 28692573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of 1% atropine eye drops in retarding progressive axial myopia in Indian eyes.
    Kothari M; Rathod V
    Indian J Ophthalmol; 2017 Nov; 65(11):1178-1181. PubMed ID: 29133646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of different concentrations of atropine on controlling myopia in myopic children.
    Shih YF; Chen CH; Chou AC; Ho TC; Lin LL; Hung PT
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):85-90. PubMed ID: 10048351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and characteristics of patients discharged alive from hospice.
    Kutner JS; Meyer SA; Beaty BL; Kassner CT; Nowels DE; Beehler C
    J Am Geriatr Soc; 2004 Aug; 52(8):1337-42. PubMed ID: 15271123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term results of using low-concentration atropine eye drops for controlling myopia progression in schoolchildren.
    Wu PC; Yang YH; Fang PC
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):461-6. PubMed ID: 21815829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized double-blind trial of sublingual atropine vs. placebo for the management of death rattle.
    Heisler M; Hamilton G; Abbott A; Chengalaram A; Koceja T; Gerkin R
    J Pain Symptom Manage; 2013 Jan; 45(1):14-22. PubMed ID: 22795904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can ophthalmic drops cause central nervous system depression and cardiogenic shock in infants?
    Kiryazov K; Stefova M; Iotova V
    Pediatr Emerg Care; 2013 Nov; 29(11):1207-9. PubMed ID: 24196091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential problems surrounding the use of sublingually administered ophthalmic atropine for sialorrhea.
    Leung JG; Schak KM
    Schizophr Res; 2017 Jul; 185():202-203. PubMed ID: 28043733
    [No Abstract]   [Full Text] [Related]  

  • 19. [Observations on long term medication with atropine eye-drops (author's transl)].
    Schäfer WD; Sauerland HJ
    Klin Monbl Augenheilkd; 1976 Mar; 168(3):421-3. PubMed ID: 966576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of low-concentration, bisulphite-containing, intracameral epinephrine and topical atropine treatments for the prevention of intraoperative floppy iris syndrome.
    Esen F; Bulut AE; Toker E
    Cutan Ocul Toxicol; 2018 Sep; 37(3):286-290. PubMed ID: 29606019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.